REQUEST A DEMO
Total
USD $0.00
Search more companies

Ascend Bioxeutical Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Ascend Bioxeutical Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ascend Bioxeutical Sdn. Bhd. is a company based in Malaysia, with its head office in Petaling Jaya. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 17, 2011. From the latest financial highlights, Ascend Bioxeutical Sdn. Bhd. reported a net sales revenue increase of 8.2% in 2024. Its’ total assets recorded a growth of 13.21%. In 2024, Ascend Bioxeutical Sdn. Bhd.’s net profit margin decreased by 11.09%.

Headquarters
Unit C-02-08 (Lobby 4),Block C, Damansara Intan E-Business Park, No. 1, Jalan Ss 20/27
Petaling Jaya; Selangor; Postal Code: 47400

Contact Details: Purchase the Ascend Bioxeutical Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Ascend Bioxeutical Sdn. Bhd. report to view the information.
Incorporation Date:
February 17, 2011
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Ascend Bioxeutical Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
8.2%
Total operating revenue
8.2%
Operating profit (EBIT)
-59.55%
EBITDA
-59.55%
Net Profit (Loss) for the Period
-75.33%
Total assets
13.21%
Total equity
2.4%
Operating Profit Margin (ROS)
-12.17%
Net Profit Margin
-11.09%
Return on Equity (ROE)
-21.57%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?